V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330005460 | 330002613 | 1.8 | 65.4 | Curative (C) | 2017-02-17 | 2017-02-25 | UKALL14- Ph 1 Induction | 02 | null | 330023573 | SUNITINIB |
| 330005461 | 330002613 | 1.74 | 38.4 | null | 2012-11-06 | 2013-04-09 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 330023573 | HYDROXYCARBAMIDE |
| 330005462 | 330002613 | 1.66 | 11.1 | Neo-adjuvant (N) | 2013-06-04 | 2013-06-07 | Doxorubicin + Ifosfamide | N | N | 330023573 | IPILIMUMAB |
| 330005463 | 330002614 | 1.73 | 89.15 | Adjuvant (A) | 2013-05-03 | 2013-05-06 | Epirubicin (weekly) | Y | N | 330023614 | VIDE |
| 330005464 | 330007430 | 1.62 | null | Curative (C) | 2015-05-22 | 2015-06-07 | Cytarabine Low Dose | N | N | 330023617 | HYDROXYCARBAMIDE |
| 330005465 | 330010033 | 1.88 | 0 | Curative (C) | null | 2016-04-05 | Cisplatin + Pemetrexed | N | N | 330023624 | CHOP |
| 330005466 | 330002615 | null | 63.05 | Curative (C) | 2014-11-18 | 2014-11-20 | CHOP - 21 days | N | null | 330023628 | BORTEZOMIB |
| 330005467 | 330002615 | 1.75 | 65.4 | Curative (C) | 2013-12-22 | 2014-01-28 | Capecitabine 35days + RT | null | N | 330023628 | AML19 TRIAL |
| 330005468 | 330002615 | null | 55.1 | Adjuvant (A) | null | 2016-09-16 | PEMBROLIZUMAB | null | null | 330023628 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE |
| 330005469 | 330002616 | 1.74 | 64.8 | Palliative (P) | 2013-02-17 | 2013-02-17 | Azacitidine | N | N | 330023647 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 330005470 | 330002617 | 1.83 | 94.4 | Curative (C) | 2016-06-25 | 2016-06-25 | Cisplatin + Fluorouracil + RT 5day | 2 | N | 330023653 | UKALL2011 |
| 330005471 | 330007432 | 1.77 | 96 | Disease modification (D) | 2018-07-22 | 2018-07-22 | CISPLATIN + DOXORUBICIN + ETOPOSIDE | N | N | 330023657 | VIDE |
| 330005472 | 330007432 | 1.69 | 90 | Neo-adjuvant (N) | 2014-11-30 | 2014-12-02 | EOX | N | N | 330023657 | DACARBAZINE |
| 330005473 | 330011477 | 1.59 | 65.5 | Palliative (P) | 2014-12-15 | 2014-12-16 | CHOP | N | N | 330023660 | VINBLASTINE |
| 330005474 | 330011477 | 0 | 79.9 | Palliative (P) | 2014-02-03 | 2014-02-09 | Epirubicin | N | N | 330023660 | CHOP |
| 330005475 | 330012711 | 1.76 | 65.2 | Curative (C) | 2017-05-26 | 2017-06-05 | Temozolomide + RT | 02 | N | 330023662 | FLAG + IDARUBICIN |
| 330005477 | 330007433 | 1.82 | -1 | null | 2016-11-27 | 2016-11-30 | Sunitinib | N | N | 330023669 | AML17 TRIAL |
| 330005478 | 330002619 | 1.62 | 10.4 | Palliative (P) | 2014-06-29 | 2014-06-29 | EC | 2 | N | 330023675 | DOXORUBICIN + IFOSFAMIDE |
| 330005479 | 330002620 | 1.21 | 59 | Palliative (P) | 2015-06-09 | 2015-06-09 | CISPLATIN + FLUOROURACIL + RT | 2 | N | 330023679 | PEMBROLIZUMAB |
| 330005480 | 330002621 | 1.8 | 70.6 | Neo-adjuvant (N) | 2017-12-10 | 2017-12-14 | DABRAFENIB | Y | N | 330023682 | VINCRISTINE |
| 330005481 | 330002621 | null | 48.9 | Palliative (P) | 2015-10-31 | 2015-10-31 | UKALL XII Maintenance (3 months) | Y | N | 330023682 | METHOTREXATE INTRATHECAL |
| 330005482 | 330002621 | 0 | 62.7 | Curative (C) | 2014-12-04 | 2014-12-09 | Chlorambucil + Pred + Rituximab | N | N | 330023682 | DOCETAXEL |
| 330005483 | 330011478 | null | 63.6 | Curative (C) | 2014-11-16 | 2014-12-25 | CHOP R - 21 days | 02 | null | 330023701 | PEMBROLIZUMAB |
| 330005484 | 330002622 | 1.65 | 76 | Palliative (P) | null | 2015-01-02 | AML18 PILOT TRIAL | N | N | 330023703 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 330005485 | 330007435 | 1.64 | 108 | Palliative (P) | 2014-01-30 | 2014-01-30 | VAC | 02 | N | 330023705 | VIDE |
| 330005486 | 330007435 | 1.68 | null | Palliative (P) | 2014-04-01 | 2014-04-01 | IMATINIB | null | null | 330023705 | FLAG + IDARUBICIN |
| 330005487 | 330007435 | 1.53 | 96.7 | Palliative (P) | null | 2015-04-09 | Cytarabine Low Dose | N | Y | 330023705 | CISPLATIN + PEMETREXED |
| 330005488 | 330002623 | 1.65 | 0 | Palliative (P) | 2018-06-07 | 2018-06-07 | Pazopanib | N | N | 330023716 | CAV |
| 330005489 | 330002624 | null | null | Palliative (P) | 2016-10-10 | 2016-10-25 | Vinblastine weekly | N | N | 330023722 | CHLORAMBUCIL |
| 330005490 | 330002624 | 1.65 | 76 | Neo-adjuvant (N) | null | 2015-03-10 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 330023722 | BEVACIZUMAB |
| 330005491 | 330002625 | null | null | Curative (C) | null | 2016-03-25 | AML 19 TRIAL | N | N | 330023740 | CHLORAMBUCIL |
| 330005492 | 330002626 | 1.5 | 121.9 | Palliative (P) | 2016-11-07 | 2016-11-07 | EMA/CO | 02 | N | 330023743 | CVD (NEUROENDOCRINE) |
| 330005493 | 330002626 | 1.75 | 63.85 | null | 2013-12-09 | 2013-12-17 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | Y | 330023743 | IVA |
| 330005494 | 330002627 | 1.73 | 77.7 | Palliative (P) | 2014-11-26 | 2014-11-27 | Mitotane 2g | 02 | N | 330023746 | IDARUBICIN |
| 330005495 | 330002628 | null | 57.9 | Palliative (P) | 2017-10-27 | 2017-10-27 | BORTEZOMIB + RITUXIMAB | 02 | N | 330023749 | VINCRISTINE |
| 330005496 | 330007438 | 1.79 | 81.5 | Curative (C) | 2013-01-25 | 2013-01-29 | ALL UKALL60+ TRIAL | 02 | N | 330023750 | UKALL2011 |
| 330005497 | 330007438 | null | 116.25 | Palliative (P) | 2017-04-22 | 2017-04-22 | CAPECITABINE + MITOMYCIN + RT | N | null | 330023750 | CARBOPLATIN + VINCRISTINE |
| 330005498 | 330007438 | 1.52 | 73.9 | Palliative (P) | 2017-08-18 | 2017-08-24 | CAPECITABINE + CARBOPLATIN | N | N | 330023750 | UKALL2014 |
| 330005499 | 330007438 | 0 | 60 | Adjuvant (A) | 2016-08-15 | 2016-08-17 | Vincristine (weekly) | 2 | N | 330023750 | ETOPOSIDE + IFOSFAMIDE |
| 330005500 | 330007438 | 1.54 | 14.9 | Curative (C) | 2014-06-08 | 2014-06-09 | Mitotane 3 - 3.5g | N | N | 330023750 | IPILIMUMAB |
| 330005501 | 330002629 | null | 71 | Palliative (P) | 2015-07-17 | 2015-07-27 | AML17 TRIAL | N | N | 330023763 | VIDE |
| 330005502 | 330002630 | 1.61 | null | Curative (C) | null | 2015-01-31 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 330023765 | IMATINIB |
| 330005503 | 330002630 | 0 | 11.1 | Curative (C) | 2016-04-03 | 2016-04-03 | ALL UKALL2011 Ind A Sht Dex (PAsp) | N | N | 330023765 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 330005504 | 330002630 | 1.53 | 63 | Palliative (P) | 2017-10-14 | 2017-10-15 | Azacitidine | N | null | 330023765 | MIFAMURTIDE |
| 330005505 | 330002630 | 0 | 57.7 | Neo-adjuvant (N) | 2015-03-21 | 2015-03-23 | CHOP | 2 | N | 330023765 | DACARBAZINE |
| 330005506 | 330002630 | 1.56 | 44 | Adjuvant (A) | 2013-04-20 | 2013-05-06 | FEC 100 | N | N | 330023765 | EDP |
| 330005507 | 330002630 | -1 | 39.5 | Curative (C) | null | 2016-09-20 | Cetuximab + CISPLATIN + FLUOROURACIL | 99 | null | 330023765 | AZACITIDINE |
| 330005508 | 330002631 | 1.65 | 51.2 | Disease modification (D) | 2014-07-27 | 2014-08-05 | Docetaxel+Gemcitabine (no prior RT) | N | N | 330023789 | CHOP |
| 330005509 | 330002632 | 1.76 | 78.9 | null | 2017-01-02 | 2017-01-05 | CISPLATIN + VINORELBINE | N | N | 330023791 | PACLITAXEL |
| 330005510 | 330002632 | null | 97.3 | Curative (C) | null | 2015-10-13 | AML 19 TRIAL | null | null | 330023791 | FLAG + IDARUBICIN |